scorecardresearch
Add as a preferred source on Google
Monday, September 29, 2025
TopicSerum Institute India

Topic: Serum Institute India

How Serum Institute, DNDi tie-up for affordable antibody will bolster global fight against dengue

There is no specific medicine for dengue yet. If ongoing Phase III trials yield positive results, an effective, affordable & specific antiviral would be available, 'ultimately saving more lives'. 

Karan Johar’s studio sells 50% stake worth 10 bn rupees to vaccine maker Adar Poonawalla

SII CEO will buy stake through his production company, Serene Productions -- another major investment outside pharma sector after picking up 20% of social media platform Wakau Interactive in 2021.

Serum Institute to double investment in Biocon’s unit to $300 million

Under new terms of the alliance, it would pump in $150 million after converting a loan to Biocon Pharma Ltd into equity in Biocon Biologics Ltd, the company said.

Rising Covid cases in China concerning but India need not panic, says SII CEO Aadar Poonawalla

The Serum Institute CEO’s tweet came a day after the Health Ministry urged states to ramp up the genome sequencing of positive samples to keep track of newer Covid variants.

Covid on the wane, Serum Institute eyes November launch for India’s first cervical cancer shot

HPV responsible for 95% of all cervical cancer. National Technical Advisory Group on Immunisation recommended HPV vaccine's inclusion in India's Universal Immunisation Programme in 2017.

Serum Institute plans to launch Covid vaccine for children in next 6 months

Speaking at a conference Tuesday, Serum Institute of India's CEO Adar Poonawalla said the Covovax vaccine is under trial & would offer protection to children as young as 3 years.

Not in favour of mixing two Covid vaccines for better efficacy, says Cyrus Poonawalla

If cocktail vaccines are administered and if the result is not good, then SII may say that another vaccine was not good or vice versa, Poonawalla added.

DCGI grants permission to Serum Institute to manufacture Sputnik V in India

The permission has been granted for examination, test and analysis of the Sputnik vaccine at SII's licensed Hadapsar facility under certain conditions, official sources said.

Serum Institute says executive’s remarks on Covid vaccination drive is ‘not company’s view’

Suresh Jadav, executive director, Serum Institute, alleged Friday that the govt began vaccinating people without taking into account available stock of vaccines and WHO guidelines.

On Camera

A 15-point agenda for Andhra CM Chandrababu Naidu to counter Trump’s H1B visa move

I write this open letter to Chandrababu Naidu as Indian emigration and return becomes a hot issue. Many H-1B workers in the US are from Andhra Pradesh: Jaithirth Rao

Market regulator SEBI clears Adani Group of impropriety alleged by Hindenburg Research

SEBI probe concluded that purported loans and fund transfers were paid back in full and did not amount to deceptive market practices or unreported related party transactions.

India looks to procure more S-400/S-500 air defence systems from Russia

The 2018 contract with Russia for 5 S-400 systems had a follow-on clause for 5 more. S-400 was described as a 'game-changer' for shooting down 5 Pakistan fighter jets during Op Sindoor.

Something’s hidden in the Oval Office photo of Trump, Munir, Sharif. India must look closely

What Munir has achieved with Trump is a return to normal, ironing out the post-Abbottabad crease. The White House picture gives us insight into how Pakistan survives, occasionally thrives and thinks.